New Delhi, April 1 – The Controller General of Drugs in India has increased regulatory scrutiny against the unauthorized sale and promotion of drugs for type 2 diabetes, also known as GLP-1 drugs, the government said on Wednesday.In recent weeks, 49 businesses across the country, including...
cardiology
diabetes
drug marketing
drug regulation
drug sales
endocrinologists
glp-1 drugs
glucagon-like peptide-1 receptor agonists
india
internal medicine
medical specialties
pharmaceuticals
prescription drugs
regulatoryinspections
type 2 diabetes
weight loss
New Delhi, March 17 During the period from 2022-23 to 2024-25, officials from the food safety departments of respective states and Union territories, as well as the regional offices of FSSAI, analyzed more than 5.18 lakh food samples, the Rajya Sabha was informed on Tuesday.During this period...